APA

Li J., Chiu K., Wang S., Yang C., Chen C., Ho H., Hung C., Cheng C., Yang C., Chen C., Wang S., Lin C., Chang C., Hsu C. & Ou Y. (2017). Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel. : Frontiers in pharmacology.

Chicago

Li Jian-Ri, Chiu Kun-Yuan, Wang Shian-Shiang, Yang Cheng-Kuang, Chen Chuan-Shu, Ho Hao-Chung, Hung Chi-Feng, Cheng Chen-Li, Yang Chi-Rei, Chen Cheng-Che, Wang Shu-Chi, Lin Chia-Yen, Chang Chao-Hsiang, Hsu Chiann-Yi and Ou Yen-Chuan. 2017. Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel. : Frontiers in pharmacology.

Harvard

Li J., Chiu K., Wang S., Yang C., Chen C., Ho H., Hung C., Cheng C., Yang C., Chen C., Wang S., Lin C., Chang C., Hsu C. and Ou Y. (2017). Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel. : Frontiers in pharmacology.

MLA

Li Jian-Ri, Chiu Kun-Yuan, Wang Shian-Shiang, Yang Cheng-Kuang, Chen Chuan-Shu, Ho Hao-Chung, Hung Chi-Feng, Cheng Chen-Li, Yang Chi-Rei, Chen Cheng-Che, Wang Shu-Chi, Lin Chia-Yen, Chang Chao-Hsiang, Hsu Chiann-Yi and Ou Yen-Chuan. Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel. : Frontiers in pharmacology. 2017.